Trial Profile
A Single-centre, Randomised, double-blind, placebo-controlled, multiple-dose study to evaluate the safety, tolerability and pharmacokinetics of Alicapistat in Healthy Elderly subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Aug 2018
Price :
$35
*
At a glance
- Drugs Alicapistat (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Pharmacokinetics
- 21 Aug 2018 New trial record